title: Pulmonary hypertension therapy and COPD: still many questions to be answered.
authors.forename: A K
authors.initials: AK
authors.lastname: Boutou
authors.forename: I
authors.initials: I
authors.lastname: Stanopoulos
authors.forename: G
authors.initials: G
authors.lastname: Pitsiou
authors.forename: P
authors.initials: P
authors.lastname: Argyropoulou
mesh_terms: D000077300:Bosentan; D015444:Exercise; D006801:Humans; D006976:Hypertension, Pulmonary / Q000150:complications* / Q000188:drug therapy*; D010477:Perfusion; D011651:Pulmonary Artery / Q000473:pathology; D029424:Pulmonary Disease, Chronic Obstructive / Q000150:complications* / Q000473:pathology; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D013449:Sulfonamides / Q000494:pharmacology; D016896:Treatment Outcome; D018487:Ventricular Dysfunction, Left
chemical_list: D013449:Sulfonamides; D000077300:Bosentan